The Latest in COVID-19 News: Week Ending May 2

By the Editors

This week, the FDA issued an emergency use authorization for remdesivir for novel coronavirus disease (COVID-19) after several studies — including two randomized, placebo-controlled trials — suggested a potential benefit in severe disease. Another study suggested that having COVID-19 patients self-prone in the emergency department could help improve oxygen saturation. Elsewhere, the CDC added new symptoms, like chills and sore throat, to its list of possible COVID-19 symptoms, and the World Health Organization expressed concern about the potential for recovered patients to not be immune to reinfection. Catch up on these and all of our COVID-19 stories from the past week at the links below.